Filing Details
- Accession Number:
- 0001209191-23-027374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-04 16:51:48
- Reporting Period:
- 2023-05-02
- Accepted Time:
- 2023-05-04 16:51:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-02 | 1,411 | $350.32 | 38,302 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 42 | $351.65 | 38,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 169 | $353.24 | 38,091 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-03 | 2,053 | $350.44 | 36,038 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-03 | 728 | $351.60 | 35,310 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1, which was entered into on 08/10/2022.
- Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $350.32 (range $350.00 to $350.92).
- Open market sales reported on this line occurred at a weighted average price of $351.65 (range $351.48 to $351.80).
- Open market sales reported on this line occurred at a weighted average price of $353.24 (range $353.21 to $353.49).
- Open market sales reported on this line occurred at a weighted average price of $350.44 (range $350.00 to $350.94).
- Open market sales reported on this line occurred at a weighted average price of $351.60 (range $351.01 to $352.00).
Billionaire Hedge Funds
